Retinoblastoma tumor suppressor protein in pancreatic progenitors controls α- and β-cell fate.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 23946427.
- Also identified by DOI 10.1073/pnas.1303386110 and PMC identifier 3767525.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Pancreatic endocrine cells expand rapidly during embryogenesis by neogenesis and proliferation, but during adulthood, islet cells have a very slow turnover. Disruption of murine retinoblastoma tumor suppressor protein (Rb) in mature pancreatic β-cells has a limited effect on cell proliferation. Here we show that deletion of Rb during embryogenesis in islet progenitors leads to an increase in the neurogenin 3-expressing precursor cell population, which persists in the postnatal period and is associated with increased β-cell mass in adults. In contrast, Rb-deficient islet precursors, through repression of the cell fate factor aristaless related homeobox, result in decreased α-cell mass. The opposing effect on survival of Rb-deficient α- and β-cells was a result of opposing effects on p53 in these cell types. As a consequence, loss of Rb in islet precursors led to a reduced α- to β-cell ratio, leading to improved glucose homeostasis and protection against diabetes.
Medical subject headings
- Glucagon-Secreting Cells
- Insulin-Secreting Cells
- Islets of Langerhans
- Retinoblastoma Protein
- Stem Cells